02052nas a2200349   4500000000100000008004100001260001300042653001500055653001000070653000900080653002200089653001400111653001000125653001700135653001100152653001900163653001100182653001400193653001200207653000900219653001600228653001200244100002400256700001400280245006300294856005700357300000900414490000700423050002200430520123600452022001401688       2006                            d  c2006 Jan10aAdolescent10aAdult10aAged10aAged, 80 and over10aBlindness10aChild10aEye diseases10aFemale10aHealth Surveys10aHumans10aIncidence10aleprosy10aMale10aMiddle Aged10aNigeria1 aWaziri-Erameh M J M1 aOmoti A E00aOcular leprosy in Nigeria: a survey of an Eku leprosorium.  uhttp://tdo.sagepub.com/content/36/1/27.full.pdf+html  a27-80 v36  aWAZIRIERAMEH 20063 a<p>To determine the ocular morbidity, visual disability and potential for blindness in leprosy patients recently released from treatment. In-patients from Eku leprosy settlement were interviewed and examined for ocular disease from leprosy and other causes. They were examined using the Snellen's chart, pentorch, Kowa portable slit-lamp, direct ophthalmoscope and the pulsair non-contact tonometer. The patients were also refracted. In all, 60 inpatients who were recently released from treatment, comprising 39 men (65%) and 21 women (35%), were examined. Fifty-eight patients (96.67%) had ocular symptoms, the most common being blurred vision in 23 patients (38.33%). Nine patients (15%) were blind. Cataract was the most common cause of blindness occurring in three of the nine patients (33.33%). The most common types of ocular lesions were madarosis (31.67%), lagophthalmos (16.67%) and cataract (16.67%). Potentially blinding conditions due to leprosy were seen in 42 patients (70%). The incidence of ocular involvement, blindness and potentially blinding conditions are high in leprosy patients recently released from treatment. Regular ophthalmic evaluation and integration into Vision 2020 programmes are recommended.</p>  a0049-4755